Compare Menopause, HRT and Women's Hormone Providers

Hormone changes often begin years before menopause

Menopause marks one point in a longer biological transition.

Estrogen, progesterone, testosterone and thyroid hormones affect sleep, mood, cognition, bone density, body composition and sexual function. Their levels and patterns shift throughout adulthood.

Perimenopause often brings the most erratic changes:

• Estrogen rises and falls unpredictably.
• Progesterone declines as ovulation becomes less consistent.
• Testosterone may decrease gradually.
• Thyroid disorders can produce similar symptoms.

Hot flashes, broken sleep, brain fog, joint pain, mood changes, lower libido and vaginal dryness may appear while periods remain regular. That makes the problem easy to dismiss and harder to diagnose.

Menopause begins after 12 consecutive months without a period. Symptoms may persist for years.

Many women still receive fragmented care across primary care, gynecology and endocrinology. Telehealth companies saw the gap.

Access improved. Consistency did not.

HRT treats symptoms, not aging itself

Hormone replacement therapy usually involves estrogen, progesterone or both. Some clinicians also prescribe testosterone when symptoms and clinical findings support it.

HRT can:

• Reduce hot flashes and night sweats.
• Improve menopause-related sleep disruption.
• Treat vaginal dryness and painful intercourse.
• Limit bone loss after menopause.
• Address specific sexual symptoms in selected patients.

Women's health platforms may also prescribe thyroid medication, vaginal estrogen, GLP-1 drugs and treatments for sexual dysfunction. A long treatment menu does not prove expertise in every condition listed.

The 2002 HRT story lacked context

The Women's Health Initiative linked hormone therapy with breast cancer, cardiovascular disease and stroke. Prescribing dropped sharply.

The findings did not apply equally to every patient or treatment.

Many study participants began therapy years after menopause, and much of the research involved oral conjugated estrogen and synthetic progestin. Current clinical decisions weigh:

• Age at treatment initiation.
• Time since menopause.
• Personal and family risk factors.
• Oral versus transdermal estrogen.
• The type of progesterone used.
• Whether the patient still has a uterus.

For many healthy women younger than 60 or within 10 years of menopause, the benefit-risk profile looks different from the original headlines.

Timing matters. Formulation does too.

Patches and pills carry different risks

Oral estrogen passes through the liver before entering circulation. That process can affect clotting factors and triglycerides.

Transdermal estrogen enters through the skin. Patches, gels and sprays avoid first-pass liver metabolism and generally produce steadier blood levels.

Clinicians often favor transdermal treatment for women with certain cardiovascular, clotting or metabolic risks. The delivery method should follow a clinical rationale, not a platform's preferred subscription model.

"Bioidentical" does not mean compounded

FDA-approved estradiol and micronized progesterone are bioidentical because their molecular structures match hormones made by the body.

Compounded hormones may use the same ingredients, but the finished products do not undergo the same FDA review for potency, purity and consistency.

Compounding has a legitimate role when a patient needs a dose or formulation that no approved product provides. That differs from claiming compounded hormones are inherently better or more natural.

Ask:

• Why is a compounded product being recommended?
• Is an FDA-approved option available?
• Which pharmacy prepares it?
• How does the pharmacy test potency and sterility?

"Customized" can describe thoughtful medicine. It can also describe a higher-margin product with weaker oversight.

Start with the prescriber

A national website does not create a national medical license.

The clinician must hold an active license where the patient receives care. Vial reviews available NPI records, state licenses and disclosed provider rosters.

Look for:

• A named prescribing clinician.
• Relevant training and experience.
• A clear follow-up process.
• Access to the clinical team when treatment changes.

A provider advertising broad coverage should show the medical network behind it.

Menopause credentials provide useful context

The Menopause Society Certified Practitioner credential identifies clinicians who have completed additional testing in menopause care.

It is not the only measure of competence. It is still a concrete signal.

A menopause platform should disclose who treats patients, what training they hold and how much of their practice focuses on midlife care.

Public records reveal what marketing does not

Vial reviews available sources including:

• OIG exclusion records.
• FDA warning letters.
• State licensing discipline.
• Pharmacy enforcement actions.
• Public recall records.

A clean search does not guarantee good medicine. A documented sanction or enforcement action deserves attention before enrollment.

The pharmacy matters

When a provider uses compounded hormones, the pharmacy controls preparation, potency, labeling and handling.

Verify:

• Active state licenses.
• Legal shipping into your state.
• Relevant accreditation.
• Inspection, recall and enforcement history.
• Any financial relationship with the provider.

Vertical integration is not inherently improper. But patients should know when the platform earns money from both the consultation and the medication it recommends.

"Physician supervised" may mean very little

One platform may assign a clinician who reviews symptoms, discusses options and adjusts treatment. Another may route an intake form through a brief approval process.

Ask direct questions:

• Will I have a named clinician?
• Who reviews my labs?
• How often is treatment reassessed?
• What happens if the first protocol fails?
• Can I choose an FDA-approved medication?

Hormone care often requires adjustment. Fast approval is not the same as ongoing care.

Get the full price before paying

The advertised number may cover only the membership.

Medication, laboratory work, shipping, follow-up visits and dose changes often cost extra. Ask for the expected monthly total before entering payment information.

Women's hormone care now sits between patients demanding access, regulators policing reckless prescribing and companies building recurring revenue around a need traditional medicine neglected. The providers worth watching are the ones willing to show how their care, and their economics, actually work.

HRT & Hormone Health Guides

Women's health providers scored by Vial

Sorted by Vial Score. Showing 8 of 8 providers. See all women's health providers →